SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 6 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,448,644 | -2.4% | 20,200 | -7.8% | 0.00% | 0.0% |
| Q2 2023 | $2,507,988 | -75.6% | 21,900 | -70.7% | 0.00% | -83.3% |
| Q1 2023 | $10,295,901 | +180.8% | 74,700 | +164.0% | 0.01% | +100.0% |
| Q4 2022 | $3,667,114 | +153.3% | 28,300 | +116.0% | 0.01% | +200.0% |
| Q3 2022 | $1,448,000 | -46.2% | 13,100 | -56.2% | 0.00% | 0.0% |
| Q4 2021 | $2,692,000 | +1.9% | 29,900 | -12.1% | 0.00% | -33.3% |
| Q2 2021 | $2,643,000 | -38.4% | 34,000 | -41.0% | 0.00% | -50.0% |
| Q1 2021 | $4,293,000 | -25.5% | 57,600 | +70.4% | 0.01% | -14.3% |
| Q4 2020 | $5,763,000 | +173.6% | 33,800 | +125.3% | 0.01% | +133.3% |
| Q3 2020 | $2,106,000 | +13.2% | 15,000 | +29.3% | 0.00% | -25.0% |
| Q2 2020 | $1,860,000 | +18.8% | 11,600 | -27.5% | 0.00% | +33.3% |
| Q1 2020 | $1,565,000 | -71.5% | 16,000 | -62.4% | 0.00% | -78.6% |
| Q4 2019 | $5,484,000 | +229.4% | 42,500 | +92.3% | 0.01% | +180.0% |
| Q3 2019 | $1,665,000 | -70.9% | 22,100 | -41.2% | 0.01% | -72.2% |
| Q2 2019 | $5,713,000 | -9.2% | 37,600 | -28.8% | 0.02% | -21.7% |
| Q1 2019 | $6,293,000 | – | 52,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 962 | $16,401,000 | 0.61% |
| GROUP ONE TRADING, L.P. | 183,600 | $31,302,000 | 0.05% |
| SIMPLEX TRADING, LLC | 950 | $16,196,000 | 0.02% |
| JPMORGAN CHASE & CO | 417,600 | $71,197,000 | 0.01% |
| IMC-Chicago, LLC | 33,800 | $5,763,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |